Scholars Central

Conference abstractPublished 20 Mar 2017

IPSC derived MSC and MSC engineering

Authors: Mahendra S Rao

Q Therapeutics, Inc, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Mesenchymal stem cells have been approved for therapy in multiple geographies and for multiple indications. However, manufacturing from an adult source has been a challenge for allogeneic use. We have proposed that MSC derived from IPSC may solve this sourcing issue and offer several advantages such as the ability to prospectively identify the right allelic phenotype and the possibility of genetically modifying the cells to enhance their utility.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Mahendra S Rao”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels